YM BioSciences - Ownership and Business Overview

Life ScienceCompany

YM BioSciences Ownership

Who owns YM BioSciences?

YM BioSciences is owned by Gilead Sciences. It was acquired on December 12, 2012.

YM BioSciences Business Overview

Where is YM BioSciences headquartered?

YM BioSciences is headquartered in Mississauga, Ontario.

How many employees does YM BioSciences have?

YM BioSciences has 32 employees.

What sector is YM BioSciences in?

YM BioSciences is a life science company.

When was YM BioSciences founded?

YM BioSciences was founded in 1994.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

YM BioSciences, Inc.

Building 11, Suite 400, 5045 Orbitor Drive,
Mississauga, Ontario L4W 4Y4
Canada,
(905)629-9761

YM BioSciences Inc. is a drug development company primarily focused on advancing CYT387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. Positive interim results have been reported from a Phase 1/2 trial of CYT387 in 166 patients with myelofibrosis.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.